BioView Company

BioView develops, manufactures, and markets an innovative automated cell diagnostic platform for use in cytogenetics, pathology, and cytological laboratories. The company’s Duet™ platform provides automated detection, classification, analysis, and counting of cells of interest selected for diagnosis and study. The Duet™ bright light illumination imaging is used to perform cell morphology as well as chromosomal analysis, and fluorescent illumination imaging is used for protein and genetic analysis. BioView’s core technology resides in its utilization of a fully motorized fluorescent and bright-field microscope equipped with a high resolution camera controlled by proprietary-self developed imaging, analysis and review software.
Technology: Health Care
Industry: Personalized Medicine
Headquarters: Rehovot, Israel
Founded Date: 2000
Employees Number: 10-5
Funding Status: N/A

Visit Website
Register and Claim Ownership